Rigel Pharmaceuticals | Capitalização De Mercado





Capitalização De Mercado Alterar Data
Agenus USD 204M 164M 2025-06
Amgen USD 201.45B 25.2B 2026-02
Anika Therapeutics USD 379M 166M 2025-06
Arrowhead Research USD 8.04B 973M 2026-02
AstraZeneca USD 222.33B 65.82B 2026-02
BioMarin Pharmaceutical USD 10.4B 142M 2025-09
Bristol-Myers Squibb USD 123.58B 13.77B 2026-02
Celldex Therapeutics USD 1.72B 367M 2025-09
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 1.01T 3.37B 2026-02
Halozyme Therapeutics USD 8.58B 2.17B 2025-09
Heron Therapeutics USD 145M 6M 2023-09
Intrexon USD 363M 69M 2023-09
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
Ligand Pharmaceuticals USD 3.42B 1.23B 2025-09
MacroGenics USD 114M 8M 2026-02
Neurocrine Biosciences USD 13.92B 1.48B 2025-09
Pfizer USD 152.89B 11.32B 2026-02
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Rigel Pharmaceuticals USD 188M 36M 2023-09
Ultragenyx Pharmaceutical USD 2.9B 539M 2025-09
Veracyte USD 2.7B 584M 2025-09


Rigel Pharmaceuticals Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.